Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg for 4 weeks (a non-therapeutic initiation dose to improve tolerability), then increased every 4 weeks to reach a therapeutic dose of 5-15 mg weekly based on response and tolerability
Risk of infection, air embolism, and anaphylaxis precludes self-administration
Head Neck Surg
pH Sensitivity: Certain extremely delicate proteins may require a specific buffer to maintain stability
May extend shelf life to: 45-60 days depending on formulation Pharmacy should provide specific expiration guidance If unsure: Follow standard 28-30 day rule
This product is not a dietary supplement
US$ 24.57
US$ 25.64
US$ 28.85
US$ 24.39
US$ 21.39
